A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations
- 1 December 1981
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 29 (26), 2803-2813
- https://doi.org/10.1016/0024-3205(81)90541-5
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Drug delivery systemsPharmacology & Therapeutics, 1981
- Valproic acid and several metabolites: quantitative determination in serum, urine, breast milk and tissues by gas chromatography—mass spectrometry using selected ion monitoringJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- The osmotic pump: novel research tool for optimizing drug regimensBiomaterials, 1981
- Valproic acid dosage and plasma protein binding and clearanceClinical Pharmacology & Therapeutics, 1980
- MATERNO-FETAL PHARMACOKINETICS AND FETAL DISTRIBUTION OF VALPROIC ACID IN A PREGNANT RHESUS-MONKEY1980
- Clinical Pharmacokinetics of Valproic Acid1Clinical Pharmacokinetics, 1980
- Valproic AcidArchives of Neurology, 1979
- Determination of valproic acid (DI-N-propyl acetic acid) in plasma by gas-liquid chromatography with pre-column butylationClinica Chimica Acta; International Journal of Clinical Chemistry, 1979
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 1979
- SERUM-PROTEIN BINDING AND PHARMACOKINETICS OF VALPROATE IN MAN, DOG, RAT AND MOUSE1978